TrestoloneAlias:19-nor-7a-methyl***;7-ALPHA-METHYL-19-NOR***;7α-Methyl-19-nor***CAS:3764-87-2MolecularFormula:C19H28O2MolecularWeight:288.42Density:1.119g/cm3BoilingPoint:439.4℃at760mmHgFlashPoint:187.3℃Package:1kg/tin,orasyourequireProperties:colorlessliquid.Usage:***anditsestersarewidelyusedforandrogenreplacementtherapy.------------------------------------------------------PharmaceuticalRawMaterialsCAS6157-87-5TrestoloneAcetateforTreatmentofHyperplasiaofProstateandBodybuildingQuickDetails:Productname:TrestoloneacetateCASNo.:6157-87-5Synonyms:17β-Hydroxy-7α-methylestr-4-en-3-oneacetate;3-Oxo-7α-methylestra-4-ene-17β-olacetate;Aceticacid3-oxo-7α-methylestra-4-ene-17β-ylester;NSC-69948;U-15614MolecularFormula:C21H30O3MeltingPoint:447.571°Cat760mmHgMolecularWeight330.47FlashPoint:194.228°Density:1.117g/cm3Appearance:WhitepowderUsage:Pharmaceuticalrawmaterials,bodybuildingandsexenhancementProductDescription:Chemicallyspeaking,trestoloneacetate(MENT)actuallyanalrightlookingdrug.Itdoesn’tshowmuchinteractionwithSexHormoneBindingGlobulin,whichmeansthatagoodportionoughttostayunboundandactiveintheblood.Also,thedrugisapotentbindertotheandrogenreceptor,whileshowingminimalaffinityfortheprogesteroneandmineralocorticoidreceptorsrespectively.Sinceitisnotabletobe5a-reducedintoadihydro-version,itlikelywouldn’tcausemanyofthesideeffectscommonlyassociatedwithDihydro***.Thisisalsoalikelyreasonthatitislessapttocauseprostateenlargement,andmayevenbeindicatedforthetreatmentofspecificprostateissues.Theabilityof7alpha-methyl-19-nor***acetate(MENT)toincreasetheweightsofventralprostateandseminalvesiclesofcastratedratswasfourtimeshigherthanthatof***,whileitseffectontheweightsofbulboc***ernosuspluslevatoranimuscles(muscle),was10timesthatof***.VariousformsofMENTinhumanpharmaceuticalpreparati***anddevicesforcontraceptionandhormonetherapy,specificallyMENTAcimplantandMENTtransdermalgelandpatchformulati***,arecurrentlyunderclinicalinvestigation.MENTisabsorbedtransdermallyuptothreetimestherateof***-17methyl***and17-αmethyl***.MENTwillh***eapplicationinawiderangeofindicati***beyondandrogenreplacementtherapyandcontraception,including,withoutlimitation,primaryhypogonadi***,testicularfailure,ASIH,baldness,sarcopenia,lossofbonemass,musclewastingandcachexia,BPH,prostatecancerandofcourse,bodybuildingandsportsperformanceenhancement.TrestoloneacetateisthechemicalnameofactiveingredientinMENT.MENTisaregisteredtrademarkofPopulationCouncil,Inc.intheUnitedStatesand/orothercountries.ProductList:ProductnameCASNO.ProductnameCASNO.Benzocaine94-09-7Procaine59-46-1DapoxetineHydrochloride129938-20-1TetracaineHCl136-47-0ClobetasolPropionate25122-46-7L-Thyroxine51-48-9Finasteride98319-26-7Dydrogesterone152-62-5Theophylline58-55-9/5967-84-0Valdecoxib181695-72-7Azithromycin117772-70-0ProcaineHCl51-05-8LidocaineHCl73-78-9Lidocaine137-58-6Dexamethasone50-02-2Dapoxetine119356-77-3L-Epinephrinehydrochloride55-31-2/329-63-5Chloramphenicol56-75-7/2787-09-9***hydrochloride25316-40-9Benzylalcohol100-51-6P***itaxel33069-62-4Omeprazole73590-58-6/119141-89-8Benzylbenzoate120-51-4Dutasteride164656-23-9Cyanocobalamin68-19-9/18195-32-9/13408-78-1BenzocaineHCl23239-88-5Furazolidone67-45-8Formestane566-48-3Rifaximin80621-81-4Acetaminophen103-90-2Paromomycin7542-37-2Amikacindisulfatesalt39831-55-5/149022-22-0Nitazoxanide55981-09-4Dexamethasonesodiumphosphate55203-24-2/312-93-6Secnidazole3366-95-8Trestoloneacetate6157-87-5Tinidazole19387-91-8Lincomycinhydrochloride7179-49-9ChlorhexidineGluconate18472-51-0Clotrimazole23593-75-11,3-dimethyl-pentylaminehydrochloride13803-74-21,3-Dimethylbutylaminehydrochloride71776-70-04amino-2-Methylpentanecitrate(AMPCNP)